Browsing: Health

TheraCell Inc, a leading allograft solution company, announced that its newest procedure-specific fiber graft form, the TheraFuze DBF Fiber Bag, is now available for use in spinal and orthopedic surgeries, including minimally invasive procedures. Additionally, the company announced that a patent related to the Fiber Bag was issued by the United States Patent and Trademark Office last year.The TheraFuze DBF Fiber Bag is a 100% allograft tissue alternative to the resorbable polymer mesh bag products that are currently on the market. The Fiber Bag is made from cortical demineralized bone fibers and processed using TheraCell’s proprietary Bone Textile™ technology. TheraCell’s…

Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that the Company has entered into a supply agreement with the government of the Republic of Korea to provide 40 million doses of the Moderna COVID-19 Vaccine to support the government’s aim of providing vaccines to the public as soon as possible. Under the terms of the proposed agreement, deliveries would begin in May 2021.Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins…

Colin Sapire, founder of the NutriBullet and innovator behind personal blending products for more than a decade, announced the launch of wellness brand Beast Health™, and the debut of its design-forward personal blender and hydration system – the B10+.Beast Health™ is on a mission to empower users to become Strong Inside™. Beast Health’s flagship B10 Health Blender is a revolution in personal blending, combining incomparable elegance and high-performance technology; and providing the perfect solution for those looking to elevate their nutrition and hydration game.The B10 Health Blender balances artful design with best-in-class technology to produce the smoothest, nutrient-rich blends imaginable.…

Hoth Therapeutics, Inc., a biopharmaceutical company, announced it has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer’s disease. Hoth also secured an exclusive license agreement with respect to the use of this drug for other indications. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is associated with the destruction of higher brain structures, such as those involved in memory and cognition. The disease leads to deficits in cognitive function and declines in memory, learning, language, and in the ability to perform…